Bhakay Anagha, Azad Mohammad, Vizzotti Emanuel, Dave Rajesh N, Bilgili Ecevit
Otto H. York Department of Chemical, Biological, and Pharmaceutical Engineering, New Jersey Institute of Technology , Newark, NJ , USA.
Drug Dev Ind Pharm. 2014 Nov;40(11):1509-22. doi: 10.3109/03639045.2013.831442. Epub 2013 Aug 28.
Nanocomposite microparticles (NCMPs) incorporating drug nanoparticles and wet-milled swellable dispersant particles were investigated as a surfactant-free drug delivery vehicle with the goal of enhancing the nanoparticle recovery and dissolution rate of poorly water-soluble drugs. Superdisintegrants were used as inexpensive, model, swellable dispersant particles by incorporating them into NCMP structure with or without wet-stirred media milling along with the drug. Suspensions of griseofulvin (GF, model drug) along with various dispersants produced by wet-milling were coated onto Pharmatose® to prepare NCMPs in a fluidized bed process. Hydroxypropyl cellulose (HPC, polymer) alone and with sodium dodecyl sulfate (SDS, surfactant) was used as base-line stabilizer/dispersant during milling. Croscarmellose sodium (CCS, superdisintegrant) and Mannitol were used as additional dispersants to prepare surfactant-free NCMPs. Nanoparticle recovery during redispersion and dissolution of the various GF-laden NCMPs were examined. Suspensions prepared by co-milling GF/HPC/CCS or milling GF/HPC/SDS were stable after 30 h of storage. After drying, due to its extensive swelling capacity, incorporation of wet-milled CCS in the NCMPs caused effective breakage of the NCMP structure and bursting of nanoparticle clusters, ultimately leading to fast recovery of the GF nanoparticles. Optimized wet co-milling and incorporation of CCS in NCMP structure led to superior dispersant performance over incorporation of unmilled CCS or physically mixed unmilled CCS with NCMPs. The enhanced redispersion correlated well with the fast GF dissolution from the NCMPs containing either CCS particles or SDS. Overall, swellable dispersant (CCS) particles, preferably in multimodal size distribution, enable a surfactant-free formulation for fast recovery/dissolution of the GF nanoparticles.
研究了包含药物纳米颗粒和湿磨可溶胀分散剂颗粒的纳米复合微粒(NCMPs)作为无表面活性剂药物递送载体,目的是提高难溶性药物的纳米颗粒回收率和溶解速率。通过将超级崩解剂与药物一起或不经过湿搅拌介质研磨而纳入NCMP结构中,将其用作廉价的模型可溶胀分散剂颗粒。将灰黄霉素(GF,模型药物)与通过湿磨制备的各种分散剂的悬浮液涂覆在Pharmatose®上,以流化床工艺制备NCMPs。在研磨过程中,单独使用羟丙基纤维素(HPC,聚合物)和与十二烷基硫酸钠(SDS,表面活性剂)一起用作基线稳定剂/分散剂。交联羧甲基纤维素钠(CCS,超级崩解剂)和甘露醇用作额外的分散剂,以制备无表面活性剂的NCMPs。检查了各种载GF的NCMPs在再分散和溶解过程中的纳米颗粒回收率。通过共研磨GF/HPC/CCS或研磨GF/HPC/SDS制备的悬浮液在储存30小时后是稳定的。干燥后,由于其广泛的溶胀能力,将湿磨的CCS纳入NCMPs中导致NCMP结构有效破裂和纳米颗粒簇破裂,最终导致GF纳米颗粒快速回收。优化的湿共研磨和将CCS纳入NCMP结构导致比纳入未研磨的CCS或将未研磨的CCS与NCMPs物理混合具有更好的分散剂性能。增强的再分散与从含有CCS颗粒或SDS的NCMPs中快速溶解GF密切相关。总体而言,可溶胀分散剂(CCS)颗粒,优选具有多峰尺寸分布,能够实现用于GF纳米颗粒快速回收/溶解的无表面活性剂制剂。